Published • loading... • Updated
NIH Identifies Cellular Process that Affects the Effectiveness of Ozempic.
Summary by omniletters.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Researchers at the National Institutes of Health (NIH) have discovered a cell signaling process in the brain that influences the effectiveness of semaglutide, a drug used for weight loss. The research may contribute to the development of more effective treatments with GLP-1 class drugs. The investigation revealed that semaglutide, a GLP-1 receptor agonist, acts on specific areas of the brain, but the internal mechanisms of the target cells were …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
